Bharat Biotech submits data on COVID-19 drug clinical trial in children
Indian drugmaker Bharat Biotech said on Wednesday data on clinical trials for its COVID-19 vaccine, Covaxin, conducted on children aged 2 to 18 has been submitted to the country’s drug regulator.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.